Saif M. U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer. JOP [Internet]. 10Nov.2013 [cited 20May2024];14(6):686-8. Available from: http://www.serena.unina.it/index.php/jop/article/view/2028